Cortex aims to transform the diagnosis and treatment of atrial arrhythmias by providing insight into each individual patient's disease pathophysiology.

The OptiMap™ System is a 510(k) cleared, AI-designed electrographic flow (EGF) mapping solution that enables physicians to "See What Matters" by visualizing and personalizing treatment for atrial fibrillation (AF).

It calculates Electrographic Flow™ from unipolar electrogram signals recorded by the 64-electrode OptiMap™ basket catheter, reconstructing the chaotic electrical conduction of AF to identify active sources and wavefront propagation patterns.

This innovative approach allows for more effective and customized ablation strategies, minimizing unnecessary heart tissue destruction while optimizing clinical success for patients.

Cortex leverages multimodal AI in medical technology to drive new solutions and improve patient outcomes in the treatment of atrial arrhythmias.